Cargando...
Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
Several treatments are currently available for relapsing-remitting multiple sclerosis. Among them, interferon (IFN) beta remains a valid treatment approach because of its good benefit/risk profile. Due to the need for frequent administration (weekly, at a minimum), the use of IFN beta is limited by...
Gardado en:
| Publicado en: | Ther Clin Risk Manag |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4431469/ https://ncbi.nlm.nih.gov/pubmed/26056458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S69123 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|